High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events
Abstract Background Brachytherapy (BT) is a vital component of the curative treatment of locally advanced cervical cancer. The American Brachytherapy Society has published guidelines for high dose rate (HDR) BT with recommended dose limits. However, recent reports suggest lower doses may be needed t...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-07-01
|
| Series: | Radiation Oncology |
| Online Access: | http://link.springer.com/article/10.1186/s13014-018-1074-2 |